Fragility analysis should complement statistical reporting in thrombosis trials: lessons from reduced-dose direct oral anticoagulants for cancer-associated venous thromboembolism

Journal of Thrombosis and Haemostasis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles